vimarsana.com
Home
Live Updates
Low-Dose Rituximab Effective Against MuSK-Positive MG in New Analysis : comparemela.com
Low-Dose Rituximab Effective Against MuSK-Positive MG in New Analysis
Following implementation of low-dose rituximab as standard of care for muscle-specific kinase–positive myasthenia gravis (MuSK-MG), a hospital evaluated the treatment’s efficacy over a 2-year period.
Related Keywords
Neurosci Lett ,
Michael Benatar ,
Shanxi Medical University ,
Myasthenia Gravis Foundation Of America ,
Neurology Department Of First Hospital ,
Image Credit ,
Neuroscience Letters ,
Neurology Department ,
First Hospital ,
Myasthenia Gravis Foundation ,
America Post Intervention Status ,
Quantitative Myasthenia Gravis ,
Myasthenia Gravis Quality ,
Low Dose Rituximab ,
Rituximab ,
Mg Adl ,
Musk Mg ,
comparemela.com © 2020. All Rights Reserved.